Total Raised

$60.5M

Investors Count

9

Deal Terms

2

Funding, Valuation & Revenue

5 Fundings

Sequana Medical has raised $60.5M over 5 rounds.

Sequana Medical's latest funding round was a IPO for $31.04M on February 11, 2019.

Sequana Medical's latest post-money valuation is from February 2019.

Sign up for a free demo to see Sequana Medical's valuations in February 2019 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

2/11/2019

IPO

$31.04M

$XXM

$X.XXB

((X.XXx))

FY XXXX

3

10/23/2015

Series C - II

$XXM

$XXM

0

FY undefined

10

4/28/2014

Series C

$XXM

$XXM

0

FY undefined

10

4/6/2011

Series B

$XXM

$XXM

0

FY undefined

0

Other Investors

$XXM

0

FY undefined

10

Date

2/11/2019

10/23/2015

4/28/2014

4/6/2011

Round

IPO

Series C - II

Series C

Series B

Other Investors

Amount

$31.04M

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

$X.XXB

((X.XXx))

FY XXXX

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

10

10

0

10

Start free trial
New call-to-action

Sequana Medical Deal Terms

2 Deal Terms

Sequana Medical's deal structure is available for 2 funding rounds, including their IPO from February 11, 2019.

Round

IPO

Series B

Funding Date

$XXM

$XXM

Pre-Money Valuation

$XXM

Post-Money Valuation

$XXM

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

IPO

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

Sequana Medical Investors

9 Investors

Sequana Medical has 9 investors. Capricorn Partners invested in Sequana Medical's Series C - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/6/2011

10/23/2015

3
Series B, Series C (2014), Series C - II (2015)

Venture Capital

Belgium

00/00/0000

00/00/0000

Entrepreneurs Fund

Subscribe to see more

Venture Capital

United Kingdom

00/00/0000

00/00/0000

Neomed Management

Subscribe to see more

Venture Capital

Norway

00/00/0000

00/00/0000

BioMedPartners

Subscribe to see more

Venture Capital

Switzerland

00/00/0000

00/00/0000

VI Partners

Subscribe to see more

Venture Capital

Switzerland

First funding

4/6/2011

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

10/23/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Entrepreneurs Fund

Neomed Management

BioMedPartners

VI Partners

Rounds

3
Series B, Series C (2014), Series C - II (2015)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Location

Belgium

United Kingdom

Norway

Switzerland

Switzerland

New call-to-action

Compare Sequana Medical to Competitors

FloShield Logo
FloShield

FloShield develops a system that includes a sheath directing CO2 gas to the tip of a laparoscope, utilizing Vortex Barrier Technology to protect the lens from condensation, debris, and smoke. This design reduces the need to remove the scope during operations. The products are compatible with both traditional and robotic laparoscopes. It was founded in 2009 and is based in Cupertino, California.

C
Coromedic

Coromedic focuses on devices and techniques for minimally invasive coronary surgery within the medical devices industry. The company provides automatic proximal and distal anastomosis for bypass surgeries and a mammary artery harvester for artery harvesting. It is based in Israel.

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

MicroTransponder Logo
MicroTransponder

MicroTransponder focuses on developing medical devices in the neuromodulation domain for chronic neurological conditions. It offers the Vivistim Paired VNS System, which stimulates the vagus nerve during rehabilitation therapy in patients with chronic ischemic stroke. It is intended for use in patients with upper extremity motor deficits following a stroke. It was founded in 2007 and is based in Austin, Texas.

C
Cardious

Cardious is a medical device company organized to develop and commercialize the AvA Aortic Valve Bypass Graft System for use as a minimally invasive, beating heart alternative to traditional aortic valve replacement therapy.

O
Orthonics

Orthonicsis a company created through Georgia Tech's Venturlab program. Orthonics is developing biomaterials for orthopaedic tissue engineering applications. The company's core technology relates to biomaterials that permit in-growth and adhesion of bone and cartilage tissues. Initial applications will be spinal disc replacement and as aspinal disc annulus patch.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.